Patents by Inventor Sydney Spector

Sydney Spector has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
    Patent number: 6277844
    Abstract: The invention provides compounds of the formula (I): wherein R1 is an amino or an alkyl group, optionally substituted with one or more groups selected from C1-C6 alkyl group; R2 is H or halogen; R3 is H, halogen, hydroxyl group, or alkyl group; R4 is H or halogen; and R5 is halogen, preferably chlorine; and salts and prodrugs thereof; and a method of using these compounds for the treatment of cancer.
    Type: Grant
    Filed: September 14, 1999
    Date of Patent: August 21, 2001
    Inventors: Sydney Spector, Neil L. Spector
  • Method for treating opiate withdrawal
    Patent number: 5512587
    Abstract: A method is disclosed for treating opiate-addicted individuals to attentuate the withdrawal syndrome comprising administering the compound levamisole in a suitable pharmaceutical carrier.
    Type: Grant
    Filed: December 19, 1994
    Date of Patent: April 30, 1996
    Inventor: Sydney Spector
  • Method for inhibiting the proliferation of tumor cells
    Patent number: 4898861
    Abstract: A method of inhibiting the proliferation of tumor cells is disclosed which comprises the treatment of such tumor cells with a benzodiazepine having a selective affinity to bind peripheral binding sites on the tumor cell in order to induce non-proliferation of said tumor cells.
    Type: Grant
    Filed: August 29, 1988
    Date of Patent: February 6, 1990
    Assignee: Hoffmann-La Roche Inc.
    Inventors: James I. Morgan, Sydney Spector, James K. T. Wang